SEARCH
MENU
The items were successfully added to the cart.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. Find out more

References

References

  1. Adibhatla and Hatcher (2006) Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic Biol Med 40:376-387
  2. Baldus et al. (2003) Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation108:1440-1445
  3. Beckman et al.  (2002) Diabetes and atherosclerosis: Epidemiology, Pathophysiology, and management. JAMA287:2570-2581
  4. Bhakdi et al. (2004) Beyond cholesterol: the enigma of atherosclerosis revisited. Thromb Haemostasis 91:639-645
  5. Clarke et al.  (2009) Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med361:2518-2528
  6. Empana et al. (2003) Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? European Heart Journal 24:1903-1911
  7. Grundy et al. (2002) Prevention Conference VI: Diabetes and Cardiovascular Disease. Circulation 105:2231-2239
  8. Holvoet et al. (1996) Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure. Thromb Haemostasis 76:663-669
  9. Holvoet et al. (1998) Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 98:1487-1494
  10. Holvoet et al. (2001) Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 21:844-848.
  11. Holvoet et al. (2002) Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the health, aging, and body composition study. Arterioscler Thromb Vasc Biol23:1444-1448
  12. Holvoet (2004) Oxidized LDL and coronary heart disease. Acta Cardiol 59: 479-484
  13. Huang et al. (1999) Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells. Arterioscler Thromb Vasc Biol 19:2640-2647
  14. Hulthe J, Fagerberg B, Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler Thromb Vasc Biol. 2002; 22:1162-1167
  15. Hörkkö et al. (1999) Monoclonal autoantibodies specific for oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest 103:117-128
  16. Itabe et al. (1994) A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides. J Biol Chem 269:15274-15279
  17. Johnston et al. (2006) Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers. Am J Cardiol 97:640-645
  18. Johnston et al. (2006) Oxidized low-density lipoprotein as a predictor of outcome in patients with unstable coronary artery disease. Int J Cardiol 113:167-173
  19. Kamstrup et al. (2009) Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA301:2331-2339
  20. Kopprasch et al. (2002) In Vivo Evidence for Increased Oxidation of Circulating LDL in Impaired Glucose Tolerance. Diabetes 51:3102-3106
  21. Libby (2002) Atherosclerosis: the new view. Sci Am 286:46-55
  22. Liu et al. (2004) Circulating oxidized low-density lipoprotein and its association with carotid intima-media thickness in asymptomatic members of familial combined hyper-lipidemia families. Arterioscler Thromb Vasc Biol 24:1492-1497
  23. Meisinger et al. (2005) Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 112:651-657
  24. Ndrepepa et al. (2008) Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes. Eur J Clin Invest 38:90-96
  25. Palinski et al. (1996) Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest98:800-814
  26. Rhodas et al. (1986). Lp(a) Lipoprotein as a risk factor for myocardial infarction. JAMA 256:2540–2544
  27. Rosengren et al. (1990) Lipoprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. Br Med J 301:1248–1251
  28. Scheffer et al. (2003) Associations of LDL with in vitro oxidizability and plasma levels of in vivo oxidized LDL in Type 2 diabetic patients. Diabetic Medicine 20:563-567
  29. Sigurdardottir et al. (2002) Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study). J Internal Med 252:440-447
  30. Thanassoulis and O'Donnell (2009) Mendelian randomization: nature's randomized trial in the post-genome era. JAMA 2009 301:2386-2388
  31. Wallenfeldt et al. (2002) Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men. J Internal Medicine 256:413-420
  32. Young and McEneny (2001) Lipoprotein oxidation and atherosclerosis. Biochem Soc Trans 29:358-362